◈ DISCLOSURE · AI-assisted editorial summary. As an Amazon Associate, ClearValue Books earns from qualifying purchases.

◈ BOOK REVIEW · INVESTING

America's growth stocks

Name: America's growth stocks
Author: Thomas R Drey

by Thomas R Drey · 1992

Who this is for

For investors who understand financial statements and want a repeatable screening process for identifying growth stocks before consensus catches up — particularly useful for those new to growth investing who want process over theory.

Buy on Amazon →🎧 Listen on Audible →

Curated by Brian Kim, CPA — every pick gets a plain-English summary and the key takeaways.

Brian Kim, CPA · 2.89M YouTube Subscribers →

◈ KEY TAKEAWAYS

What this book actually teaches

01Growth stocks are mispriced when analysts focus on current earnings rather than multi-year trajectory — the edge is in identifying durable growth early.
02Drey's screening process filters on revenue growth, margin expansion in down cycles, management quality, and competitive moats — in that order.
03Exit decisions should be tied to deteriorating fundamentals, not arbitrary price targets.
04The book's methodology is sound but requires a separate valuation discipline to avoid overpaying for genuine growth companies.
05Case studies are from the 1970s–80s; treat screening thresholds as a starting framework to update for current market conditions.

◈ THE SUMMARY

What's in this book

Scored against ClearValue's published methodology · Jun 28, 2026

Thomas Drey's 1992 guide argues that ordinary investors can beat the market by identifying and holding shares in companies with above-average earnings growth potential — before Wall Street consensus catches up. The thesis is straightforward: growth stocks are mispriced because analysts anchor on current earnings rather than multi-year trajectory. Patient investors who learn to read leading indicators of growth can exploit that lag.

Drey walks through a systematic screening process. He starts with revenue and earnings growth rates, filters for companies expanding margins even in down cycles, and layers in qualitative signals: management depth, competitive moats, and barriers to entry. The screening methodology is workmanlike rather than flashy — no complex quant models, just disciplined ratio analysis and company research. The book also covers when to sell, which many growth-investing guides skip: Drey ties the exit decision to deteriorating fundamentals rather than price targets, a philosophically sound approach.

The historical case studies anchor the framework. Drey draws on real companies from the 1970s and 1980s to demonstrate how early identification of durable growth played out over time. These examples give the methodology credibility, though the specific companies are mostly dated by now.

For investors who already understand basic financial statements, the book functions as a repeatable research process rather than a philosophical manifesto. It does not dwell on market theory; it moves quickly to application.

Where it falls short

the book's 1992 vintage shows in ways that matter. The screening criteria predate widespread internet access to financial data, and the case companies are from an era when competitive dynamics looked very different. The book also gives insufficient attention to valuation — it is possible to find a genuine growth company and still overpay for the stock. Drey acknowledges the importance of not overpaying but does not give valuation its own systematic treatment. Investors who follow the framework without a valuation discipline could buy quality companies at prices that negate the growth advantage.

The verdict

a solid process-oriented introduction to growth stock selection, better as a methodology primer than a current-reference guide. Readers should treat the specific screening thresholds as starting points and update them for today's data environment.

Summary as of June 28, 2026AI-assisted summary.